Post-earnings recap
Reported
Mon, May 11, 2026
EPS actual
$0.81
EPS est.
$0.77
EPS surprise
+5.19%
1-day move
+1.21%
Novanta Inc. reported better-than-expected earnings per share, which contributed to a positive stock reaction, with shares rising by 1.21%. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. Investors may be encouraged by the EPS beat, but the lack of revenue data and guidance could lead to cautious sentiment moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.81 | $0.78 | +5.19% |
| Revenue | N/A | $253M | N/A |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.
Novanta Inc. operates in the Information Technology sector, focusing on electronic equipment and instruments. The company is significant for its role in providing precision motion and photonics solutions, which are essential for various high-tech industries, including medical technology and automation.
Last quarter
In the last quarter, Novanta reported an EPS of $0.91, exceeding expectations by 3.41%. However, the stock experienced a decline of 2.45% the following day, indicating mixed market reactions.
Management promises and guidance
EPS beat streak
7Q
EPS beat rate
88%
Avg EPS surprise
+5.08%
Avg 1-day reaction
-0.65%
Analysts are cautiously optimistic about Novanta's upcoming earnings, expecting a slight increase in both EPS and revenue. The company has a strong history of beating earnings expectations, which could lead to positive market reactions.
Bull case
If Novanta beats the EPS estimate and shows strong revenue growth, it could signal robust demand for its products, leading to a significant stock price increase.
Bear case
Conversely, if the company misses its earnings targets or provides weak guidance, it could raise concerns about its growth prospects, resulting in a sharp decline in stock value.
Key metrics to watch
EPS
0.78Earnings per share is a key indicator of profitability and will show how well Novanta is managing costs and generating income.
Revenue
253MRevenue growth is crucial for assessing the company's ability to expand and capture market share, especially in competitive sectors.
The print will turn on these.
Q1
Will Novanta achieve an EPS of $0.78 or higher?
This figure is critical as it will indicate whether the company continues its trend of beating earnings expectations, which could influence investor confidence.
Q2
What is the revenue growth rate compared to the consensus of $253M?
Revenue performance is essential for assessing the company's market position and future growth potential, especially in a competitive landscape.
—
Est. EPS
$-1.22
Est. Rev
$3.6B
Impl. Move
±1.8%
Why consensus could be wrong
The consensus may underestimate Novanta's ability to innovate and capture new markets, particularly in the medical technology sector.
Supporting evidence
The company has consistently beaten EPS estimates in recent quarters, indicating strong management performance.
Options pricing suggests a higher expected move than historical averages, indicating potential for significant market reaction.
Insider selling may reflect strategic positioning rather than lack of confidence in the company’s future.
Key risk
If revenue growth exceeds $255M, it could challenge the current cautious outlook and shift investor sentiment positively.
Pre-commit to what would confirm each case.
The market is debating whether Novanta can maintain its growth momentum amidst competitive pressures and economic conditions.
Bull confirmed if
An EPS of $0.80 or higher with revenue exceeding $255M would confirm strong operational performance.
Bear confirmed if
An EPS below $0.76 or revenue falling short of $252M would raise concerns about the company's growth trajectory.
What the market is pricing for the move.
Implied Move
±9.27%
Historical Avg
±4.5%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±8.1% while NOVT has averaged ±4.5% over the last 8 prints — setup is pricing rich.
ATM IV
1.0%
30d HV
44.4%
Smart-money positioning from the most recent 13F filings.
Institutional
123.50%
of float
Insider
0.71%
of float
Holders
537
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
4,798,035 sh · $689.2M
12.69%
3.1%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Novanta beats expectations, history suggests the stock could rise by around 1.75%, confirming strong demand and operational efficiency.
In line / cautious
If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious investor sentiment.
Miss
If the company misses its targets, history suggests a potential decline of about 5.45%, which could raise concerns about future growth.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
1
1 buy·0 sells
Members
1
House only
Est. Notional
$1,001.00–$15,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
Vanguard Portfolio Management LLC
2,395,681 sh · $344.1M
6.33%
-3.3%
Price (T.Rowe) Associates Inc
2,222,445 sh · $319.2M
5.88%
24.6%
Allspring Global Investments Holdings, LLC
1,817,594 sh · $261.1M
4.81%
2.3%
Vanguard Capital Management LLC
1,606,928 sh · $230.8M
4.25%
-0.4%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net buying
Recent Transactions
Traded May 18, 2026 · disclosed Jun 8, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.